MIR-135b-5p and MIR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Xu, Zhiliang ^a   Han, Yeming ^b   Liu, Jiying ^c   Jiang, Fan ^b   Hu, Huili ^a   Wang, Yan ^a   Liu, Qiji ^a   Gong, Yaoqin ^a   Li, Xi ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; MESSENGER RNA; MICRORNA; MIRN135 MICRORNA, HUMAN; MIRN499 MICRORNA, HUMAN; MYOCYTE ENHANCER FACTOR 2; TRANSCRIPTOME;

3' UNTRANSLATED REGION; ADULT; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BINDING SITE; CASE CONTROL STUDY; CELL MOTION; CELL PROLIFERATION; CLUSTER ANALYSIS; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; REPRODUCIBILITY; RNA INTERFERENCE; SMOOTH MUSCLE CELL; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR SMOOTH MUSCLE;

3' UNTRANSLATED REGIONS; ADULT; ATHEROSCLEROSIS; BASE SEQUENCE; BINDING SITES; CASE-CONTROL STUDIES; CELL MOVEMENT; CELL PROLIFERATION; CLUSTER ANALYSIS; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MEF2 TRANSCRIPTION FACTORS; MICRORNAS; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLAQUE, ATHEROSCLEROTIC; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84937598291     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12276     Document Type: Article

References (43)

1. Libby, P. Inflammation in atherosclerosis. Nature 420, 868-874 (2002).
2. Ambros, V. The functions of animal microRNAs. Nature 431, 350-355 (2004).
3. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA. 105, 10513-10518 (2008).
4. Fichtlscherer, S. et al. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107, 677-684 (2010).
5. Jiang, Y. et al. Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases. Sci. Rep. 4, 5026 (2013).
6. Hoekstra, M. et al. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem. Biophys. Res. Commun. 394, 792-797 (2010).
7. Takahashi, Y. et al. Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels. Clin. Sci (Lond). 119, 395-405 (2010).
8. Fichtlscherer, S., Zeiher, A. M. & Dimmeler, S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler. Thromb. Vasc. Biol. 31, 2383-2390 (2011).
9. Raitoharju, E., Oksala, N. & Lehtimaki, T. MicroRNAs in the atherosclerotic plaque. Clin. Chem. 59, 1708-1721 (2013).
10. McKinsey, T. A., Zhang, C. L. & Olson, E. N. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 27, 40-47 (2002).
11. Han, J. & Molkentin, J. D. Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends Cardiovasc. Med. 10, 19-22 (2000).
12. Shore, P. & Sharrocks, A. D. The MADS-box family of transcription factors. Eur. J. Biochem. 229, 1-13 (1995).
13. Maiti, D., Xu, Z. & Duh, E. J. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells. Invest. Ophthalmol. Vis. Sci. 49, 3640-3648 (2008).
14. Potthoff, M. J. & Olson, E. N. MEF2: a central regulator of diverse developmental programs. Development 134, 4131-4140 (2007).
15. Lin, Q. et al. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125, 4565-4574 (1998).
16. Zhuang, G. et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. Embo. J. 31, 3513-3523 (2012).
17. Hulsmans, M. & Holvoet, P. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc. Res. 100, 7-18 (2013).
18. Sarver, A. L. et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9, 401 (2009).
19. Liu, S. et al. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J. Hepatol. 56, 389-396 (2013).
20. Halappanavar, S. et al. IL-1 receptor regulates microRNA-135b expression in a negative feedback mechanism during cigarette smoke-induced inflammation. J. Immunol. 190, 3679-3686 (2013).
21. Betel, D., Wilson, M., Gabow, A., Marks, D. S. & Sander, C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 36, D149-153 (2008).
22. Wang, X. & El Naqa, I. M. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 24, 325-332 (2008).
23. Krek, A. et al. Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500 (2005).
24. Wang, K., Zhang, S., Weber, J., Baxter, D. & Galas, D. J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 38, 7248-7259 (2010).
25. Zernecke, A. et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal 2, ra81 (2009).
26. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D. & Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433 (2011).
27. Schaap-Oziemlak, A. M. et al. MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells. Stem Cells Dev. 19, 877-885 (2010).
28. Matsuyama, H. et al. MiR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood 118, 6881-6892 (2011).
29. Hosking, B. M. et al. SOX18 directly interacts with MEF2C in endothelial cells. Biochem. Biophys. Res. Commun. 287, 493-500 (2001).
30. Davignon, J. & Ganz, P. Role of endothelial dysfunction in atherosclerosis. Circulation 109, III 27-32 (2004).
31. Turchinovich, A., Weiz, L., Langheinz, A. & Burwinkel, B. Characterization of extracellular circulating microRNA. Nucleic. Acids Res. 39, 7223-7233 (2011).
32. Arroyo, J. D. et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. USA. 108, 5003-5008 (2011).
33. Zhang, Y. et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 39, 133-144 (2010).
34. Mallat, Z. et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99, 348-353 (1999).
35. Leroyer, A. S. et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J. Am. Coll. Cardiol. 49, 772-777 (2007).
36. Rautou, P. E. et al. Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ. Res. 108, 335-343 (2011).
37. Del Conde, I., Shrimpton, C. N., Thiagarajan, P., Lopez, J. A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106, 1604-1611 (2005).
38. Fish, J. E. et al. MiR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15, 272-284 (2008).
39. Leeper, N. J. et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J. Cell Physiol. 226, 1035-1043 (2011).
40. Zhao, M. et al. Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases. Arch. Biochem. Biophys. 400, 199-207 (2002).
41. Shaul, P. W. & Mineo, C. HDL action on the vascular wall: is the answer NO? J. Clin. Invest. 113, 509-513 (2004).
42. Urbich, C., Dernbach, E., Zeiher, A. M. & Dimmeler, S. Double-edged role of statins in angiogenesis signaling. Circ. Res. 90, 737-744 (2002).
43. Zhang, J. G. et al. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/betacatenin pathway. Sci. Rep. 5, 8087 (2014).